Consolidated Statements of Profit or Loss
|
|
|
|
Year Ended December 31, |
||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
(in thousands of $ except for shares and EPS) |
|
Note |
|
2023 |
|
2022 |
|
2021 |
||||
Product net sales |
|
|
1,190,783 |
|
400,720 |
|
– |
|||||
Collaboration revenue |
|
|
35,533 |
|
10,026 |
|
497,277 |
|||||
Other operating income |
|
|
42,278 |
|
34,520 |
|
42,141 |
|||||
Total operating income |
|
|
|
1,268,594 |
|
445,267 |
|
539,418 |
||||
|
|
|
|
|
|
|
|
|
||||
Cost of sales |
|
|
|
(117,835) |
|
(29,431) |
|
– |
||||
Research and development expenses |
|
|
(859,492) |
|
(663,366) |
|
(580,520) |
|||||
Selling, general and administrative expenses |
|
|
(711,905) |
|
(472,132) |
|
(307,644) |
|||||
Loss from investment in joint venture |
|
|
|
(4,411) |
|
(677) |
|
– |
||||
Total operating expenses |
|
|
|
(1,693,643) |
|
(1,165,607) |
|
(888,164) |
||||
|
|
|
|
|
|
|
|
|
||||
Operating loss |
|
|
|
(425,049) |
|
(720,341) |
|
(348,746) |
||||
|
|
|
|
|
|
|
|
|
||||
Financial income |
|
|
107,386 |
|
27,665 |
|
3,633 |
|||||
Financial expense |
|
|
(906) |
|
(3,906) |
|
(4,578) |
|||||
Exchange gains/(losses) |
|
|
14,073 |
|
(32,732) |
|
(50,053) |
|||||
|
|
|
|
|
|
|
|
|
||||
Loss for the year before taxes |
|
|
|
(304,496) |
|
(729,314) |
|
(399,743) |
||||
Income tax benefit/(expense) |
|
|
9,443 |
|
19,720 |
|
(8,522) |
|||||
Loss for the year |
|
|
|
(295,053) |
|
(709,594) |
|
(408,265) |
||||
Loss for the year attributable to: |
|
|
|
|
|
|
|
|
||||
Owners of the parent |
|
|
|
(295,053) |
|
(709,594) |
|
(408,265) |
||||
Weighted average number of shares outstanding |
|
|
|
57,169,253 |
|
54,381,371 |
|
51,075,827 |
||||
Basic and diluted (loss) per share (in $) |
|
|
(5.16) |
|
(13.05) |
|
(7.99) |
|||||
|
||||||||||||